|
Delayed
Nasdaq Stockholm
20:00:00 15/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.280 SEK | +4.59% |
|
+2.70% | +0.88% |
| 08-20 | Lärkberget AB Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-21 | Larkberget to carry out rights issue of units totaling SEK 14.9 mln | RE |
Company Valuation: CombiGene AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 157.3 | 225.7 | 180.9 | 53.27 | 47.13 | 44.75 |
| Change | - | 43.52% | -19.87% | -70.55% | -11.52% | -5.04% |
| Enterprise Value (EV) 1 | 108.4 | 88.99 | 49.11 | -48.17 | -26.62 | 38.91 |
| Change | - | -17.9% | -44.82% | -198.1% | 44.74% | 246.16% |
| P/E | -4.17x | 9.42x | -29.4x | -1.49x | -1.05x | -3.62x |
| PBR | 2.2x | 1.43x | 1.19x | 0.46x | 0.66x | 0.81x |
| PEG | - | -0x | 0x | -0x | -0x | 0x |
| Capitalization / Revenue | 14.5x | 2.48x | 6.3x | 7.6x | 23.6x | 147x |
| EV / Revenue | 10x | 0.98x | 1.71x | -6.87x | -13.3x | 128x |
| EV / EBITDA | -4.45x | 3.84x | -2.83x | 1.34x | 0.83x | -5.41x |
| EV / EBIT | -4.03x | 3.89x | -2.78x | 1.33x | 0.7x | -3x |
| EV / FCF | -3.73x | 6.84x | -4.04x | 2.57x | 1.54x | -3.65x |
| FCF Yield | -26.8% | 14.6% | -24.7% | 39% | 65.1% | -27.4% |
| Dividend per Share 2 | - | - | - | - | 0.2 | 2 |
| Rate of return | - | - | - | - | 8.4% | 88.5% |
| EPS 2 | -3.287 | 1.21 | -0.3109 | -1.801 | -2.27 | -0.6242 |
| Distribution rate | - | - | - | - | -8.81% | -320% |
| Net sales 1 | 10.83 | 91.15 | 28.73 | 7.008 | 1.999 | 0.304 |
| EBITDA 1 | -24.37 | 23.19 | -17.36 | -35.98 | -32.12 | -7.187 |
| EBIT 1 | -26.87 | 22.89 | -17.66 | -36.31 | -37.92 | -12.98 |
| Net income 1 | -29.38 | 20.96 | -6.157 | -35.67 | -44.88 | -12.36 |
| Net Debt 1 | -48.9 | -136.7 | -131.8 | -101.4 | -73.75 | -5.842 |
| Reference price 2 | 13.720 | 11.400 | 9.135 | 2.690 | 2.380 | 2.260 |
| Nbr of stocks (in thousands) | 11,464 | 19,801 | 19,801 | 19,801 | 19,801 | 19,801 |
| Announcement Date | 04/05/21 | 27/04/22 | 26/04/23 | 26/04/24 | 12/05/25 | 02/04/26 |
1SEK in Million2SEK
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 4.62M | |
| 20.35x | 7.16x | 14.38x | 1.46% | 69.18B | |
| 31.96x | 9.24x | 44.57x | 0.04% | 62B | |
| -73.2x | 14.15x | -68.23x | -.--% | 26.19B | |
| 29.82x | 6.33x | 16.44x | -.--% | 25.75B | |
| -14.7x | 5.35x | -6.73x | -.--% | 24.29B | |
| 26.87x | 5.1x | 16.96x | -.--% | 19.84B | |
| 45.45x | 16.69x | 33.86x | 0.33% | 15.65B | |
| -14.9x | 3360.83x | -17.18x | -.--% | 13.88B | |
| 1005.79x | 35.18x | 607.6x | -.--% | 14.09B | |
| Average | 117.49x | 384.45x | 71.30x | 0.2% | 27.09B | |
| Weighted average by Cap. | 63.10x | 181.79x | 42.16x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- LARK Stock
- Valuation CombiGene AB
Select your edition
All financial news and data tailored to specific country editions
